Skip to main content

Table 4 Number of days missing from work in the previous year at baseline and one year after start of treatment.

From: Effects of glatiramer acetate on fatigue and days of absence from work in first-time treated relapsing-remitting multiple sclerosis

  Baseline After 12 Months
  N % N %
No 76 26.1% 148 50.9%
≤ 5 days 26 8.9% 27 9.3%
6–10 days 39 13.4% 14 4.8%
11–20 days 32 11.0% 8 2.8%
> 20 days 50 17.2% 18 6.2%
Not in employment 68 23.4% 62 21.3%
Missing information 0 0% 14 4.8%